WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2003055873) AMINOINDANE DERIVATIVES AS SEROTONIN AND NOREPINEPHRINE UPTAKE INHIBITORS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2003/055873    International Application No.:    PCT/DK2002/000873
Publication Date: 10.07.2003 International Filing Date: 18.12.2002
Chapter 2 Demand Filed:    19.06.2003    
IPC:
A61K 31/135 (2006.01), A61K 31/357 (2006.01), C07C 211/42 (2006.01), C07D 317/58 (2006.01), C07D 319/18 (2006.01)
Applicants: H. LUNDBECK A/S [DK/DK]; Ottiliavej 9, DK-2500 Valby-Copenhagen (DK) (For All Designated States Except US).
BØGESØ, Klaus, Peter [DK/DK]; (DK) (For US Only).
PÜSCHL, Ask [DK/DK]; (DK) (For US Only).
KEHLER, Jan [DK/DK]; (DK) (For US Only).
BREGNEDAL, Peter [DK/DK]; (DK) (For US Only)
Inventors: BØGESØ, Klaus, Peter; (DK).
PÜSCHL, Ask; (DK).
KEHLER, Jan; (DK).
BREGNEDAL, Peter; (DK)
Priority Data:
PA200101939 21.12.2001 DK
60/343,360 21.12.2001 US
Title (EN) AMINOINDANE DERIVATIVES AS SEROTONIN AND NOREPINEPHRINE UPTAKE INHIBITORS
(FR) DERIVES AMINOINDANE UTILISES COMME INHIBITEURS DE LA CAPTURE DE LA SEROTONINE ET DE LA NOREPINEPHRINE
Abstract: front page image
(EN)The present invention relates to aminoindane derivatives having the formula I wherein X, Y, U, R?1-2¿, R?13-16¿ and R are as defined in the claims, or an acid addition salt thereof. The compounds of the invention posses the combined effect of serotonin reuptake inhibition and norepinephrine uptake inhibition.
(FR)La présente invention concerne des dérivés aminoindane représentés par la formule générale (I) dans laquelle X, Y, U, R1-2, R13-16 et R désignent des éléments définis dans les revendications de la présente demande, ou un de leurs sel d'addition acide. Les composés de l'invention permettent d'inhiber la recapture de la sérotonine et la capture de la norépinéphrine.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, OM, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)